OracleBio would like to highlight a forthcoming, complimentary, webinar sponsored by Merck (hosted by Elsevier), which may be of interest to those companies wishing to gain a better perspective of what’s required for a successful licensing deal with large Pharma. The webinar will include talks from a number of individuals from within Merck including: a [...] Read more »
Looking for a licencing deal with Large Pharma? If so, it’s time to start thinking Biomarkers…
In a move reflecting the changes seen within all major pharmaceutical companies, Merck and Co. recently changed their “Areas of Interest” page on their website to highlight the importance of a robust translational biomarker strategy when looking for an in-licencing deal. The document (http://www.merck.com/licensing/areas_of_interest.pdf) now contains the a footnote at the bottom of pages 14-17 [...] Read more »